New β-Lactams: New Problems for the Internist
- 15 October 1991
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 115 (8) , 650-651
- https://doi.org/10.7326/0003-4819-115-8-650
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during TherapyAnnals of Internal Medicine, 1991
- High-level resistance to cefotaxime and ceftazidime in Klebsiella pneumoniae isolates from Cleveland, OhioAntimicrobial Agents and Chemotherapy, 1991
- Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facilityAntimicrobial Agents and Chemotherapy, 1990
- Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 1989
- Extended-spectrum beta-lactamasesAntimicrobial Agents and Chemotherapy, 1989
- Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion testsAntimicrobial Agents and Chemotherapy, 1988
- Inducible -Lactamases: Clinical and Epidemiologic Implications for Use of Newer CephalosporinsClinical Infectious Diseases, 1988
- Chromosomal Cephalosporinases Responsible for Multiple Resistance to Newer β-Lactam AntibioticsAnnual Review of Microbiology, 1987
- Outbreak of cephalosporin resistant Enterobacter cloacae infection in a neonatal intensive care unit.Archives of Disease in Childhood, 1987
- Epidemiology of enterobacteria resistant to cefotaxime in hospitalJournal of Antimicrobial Chemotherapy, 1984